Mascoma Wealth Management LLC - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Mascoma Wealth Management LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$61,650
+0.9%
5,0000.0%0.02%0.0%
Q2 2023$61,100
-1.5%
5,0000.0%0.02%
+5.6%
Q1 2023$62,050
+8.3%
5,0000.0%0.02%0.0%
Q4 2022$57,300
+201.6%
5,0000.0%0.02%
+157.1%
Q3 2022$19,000
-36.7%
5,0000.0%0.01%
-30.0%
Q2 2022$30,000
-6.2%
5,0000.0%0.01%0.0%
Q1 2022$32,000
+60.0%
5,0000.0%0.01%
+42.9%
Q4 2021$20,000
-16.7%
5,0000.0%0.01%
-22.2%
Q3 2021$24,000
-22.6%
5,0000.0%0.01%
-30.8%
Q1 2021$31,0005,0000.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,894,013$23,353,18021.09%
Newtyn Management, LLC 1,873,694$23,102,6475.70%
Sio Capital Management, LLC 288,466$3,556,7861.10%
Madison Avenue Partners, LP 553,085$6,819,5380.97%
WITTENBERG INVESTMENT MANAGEMENT, INC. 209,739$2,5860.95%
Indaba Capital Management, L.P. 136,802$1,686,7690.50%
Sepio Capital, LP 306,680$3,781,3640.33%
Yakira Capital Management, Inc. 54,118$667,2750.18%
Centiva Capital, LP 187,803$2,315,6110.05%
FIFTH LANE CAPITAL, LP 10,929$134,4270.05%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders